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Abstract
NALCN (sodium-leak channel non-selective protein) is a regulator of the pacemaker neurons responsible for rhythmic behaviour including respiration; maintaining the resting membrane potential and required for action potential production. Nalcn null mice show early death associated with disrupted respiratory rhythms characterised by frequent and profound apnoeas. We report 3 children (2 siblings) with compound heterozygous mutations in NALCN associated with developmental impairment, hypotonia and central sleep-disordered breathing causing apnoeas.  Supplemental oxygen normalised respiratory rhythm. NALCN mutations have been previously reported to cause severe hypotonia, speech impairment and cognitive delay as well as infantile neuroaxonal dystrophy and facial dysmorphism. Non-synonymous changes in the two affected extracellular loops may be responsible for the deleterious effect on the stability of respiratory rhythm. While oxygen is a known to be a stabiliser of respiratory rhythm in central apnoea in children, its role in NALCN dysfunction requires further investigation.



Introduction
NALCN is a transmembrane, pore forming protein which facilitates intracellular movement of sodium. The NALCN gene is widely expressed in the central nervous system(1) and is a critical component maintenance of resting membrane potential in excitable cells. An excellent recent review of NALCN protein function is provided by Cochet-Bissuel et al(1).
Case 1 (Family I.1)
The elder sister of our siblings was born by emergency caesarean section after failed induction of labour, post term, for oligohydramnios. Parents are non-consanguineous Caucasians. Birth weight was 3230g (Z -0.07) and occipitofrontal circumference (OFC) 34cm (Z +0.1). Hypotonia with poor suck reflex necessitated nasogastric feeding. Bottle feeding was established with specialised teats. Weight gain was slow and required calorie supplementation. At the age of 6 years her BMI was 12.6 kg/m2. She showed disturbance of sleep wake cycle. On occasion, she went without sleep for 48 hours. She has been diagnosed with Attention Deficit, Hyperactivity Disorder (ADHD). A diagnosis of global developmental delay was reached by 1 year and 3 months and she now attends a school for children with additional needs and has severe intellectual impairment. She has strabismus and hypermetropia requiring corrective lenses. Mild craniofacial dysmorphism is apparent with myopathic features (Figure 1A). Prior to this plagiocephaly gave rise to pseudo-hemihypertrophy of the face which has resolved. Aged 7 she had adenotonsillectomy following reported obstructed breathing at night. This had no effect on the underlying respiratory rhythms described below.
Case 2 (Family I:2)
The male, younger sibling was born by elective caesarean section at 39 weeks. Birth weight 3232g (Z -0.3) and OFC 36cm (Z +1.21). Similar issues to his sibling were apparent from birth including hypotonia and feeding difficulties but early use of specialised teats allowed discharge home earlier. Aged 8 his BMI was 13.7kg/m2. Though sitting at 6 months, further milestones were delayed. Speech and social skills are profoundly affected and he has been diagnosed with Autism Spectrum Disorder and learning disability. MRI brain performed aged 3 was normal. He attends a school for children with additional needs. He has strabismus and hypermetropia.
Case 3 (Family II.1)
Case 3 was born at 41 weeks gestation weighing 2850g (Z -0.88). She was noted to be hypotonic and required support feeding in the neonatal period. She had marked plagiocephaly and facial asymmetry which is still evident when she smiles. She has a tall forehead with bitemporal narrowing and deep set eyes. Brain MRI scan aged 3 was reported normal. She underwent adenotonsillectomy aged 2 and tympanostomy-tube insertion age 5 for glue-ear
She was delayed in her developmental milestones and sat at 1 year. By 19 months she was walking with one hand held but still had no speech. Assessment aged 3 highlighted difficulties with intelligibility and her expressive language and this persisted until aged 10. She started mainstream school with educational support but transferred to an additional support for learning school aged 10. Children and Adolescent Mental Health Services offer support with behaviours and anxiety. Aged 10 her BMI was 26.7kg/m2 but has plateaued on a weight management programme. She had a normal echocardiogram; ophthalmology and audiology assessments. She has joint hypermobility.
A phenotypic summary of these and other published cases is provided as a supplemental table.
Breathing abnormalities
Parents noticed an unusual breathing pattern from birth in Case 1. This was characterised as a pattern of taking 3 breaths normally then “holding her breath” with no respiratory effort for the equivalent of three breaths. Initially this was felt to be physiological apnoea but its persistence led to further investigations. Limited channel cardiopulmonary studies with the recording of airflow by thermistor were performed along with assessments of respiratory effort by inductance plethysmography, oxyhaemoglobin saturations by pulse oximetry (SpO2), carbon dioxide by transcutaneous measurement (tcCO2), single lead cardiac monitoring and video. The airflow measurement was poorly tolerated. Multiple sleep studies demonstrated frequent central apnoeas, ameliorated with oxygen therapy (Figure 1 A). A study from 2010 (aged 3) showed a rhythm of 2 breaths followed by cessation of respiratory effort giving rise to a SpO2 desaturation of >3% to the 80’s. Each event had a mean duration of 10 seconds at a frequency of 39 events per hour. Mean TcCO2 reading was 5.6kPa. The respiratory rate fell from 26 when awake to 14 when asleep. When supplemented with 1L/min of nasal cannula oxygen there were markedly fewer respiratory pauses and no drop in SpO2. Subsequent studies showed a notable periodicity to the events consistent with the effect of different stages of sleep.

Case 2 was not noticed to have abnormal breathing rhythm until he was 5 months old. A report from a sleep study performed aged 2 revealed a rhythm of 1-2 breaths then complete cessation of effort for a mean duration of 9 second with at a frequency of 37/hour and an associated drop in SpO2.TcC02 was stable circa 5.5kPa. No obstructive events were noted. With supplementation of 1L/min oxygen via nasal cannulae, respiratory pauses were less frequent and not associated with a drop in SpO2. Images are unavailable due to the study quality and data storage procedures in place at his base hospital.
Case 3 was referred for assessment at 8 months of age and had a sleep study showing a mixture of central and obstructive episodes. Adenotonsillectomy resolved the obstructive episodes. All subsequent studies have shown the overwhelming feature to be central apnoea with >100 events/hour in air and almost complete abolition of the events with 0.5 L/min of oxygen. The pattern consists of 3 or 4 breaths followed by a pause with slight increase in heart rate and drop in oxygen saturation as shown in Figure 1B. Sleep state appears to have no effect on the abnormality and there is no evidence at 10 years of age of any change in the sleep breathing abnormality.
Genetic assessment
All three children had negative screens for common genetic and metabolic causes of hypotonia and congenital central hypoventilation syndrome (CCHS).
Based on the unexplained developmental delay, cases 2 & 3 were recruited to the Deciphering Developmental Disorders (DDD) study (www.ddduk.org).  This is a UK-wide project that has recruited ~14,000 probands with undiagnosed severe or extreme developmental disorders via regional clinical genetics services in UK and Ireland with the aim of using new genome-wide technologies to identify the causative genomic variants. Trio-based whole exome sequencing was performed on Case 2 and his parents, as previously described(2). This revealed compound heterozygous mutations in two known developmental disorder genes; NALCN and TRAPPC9. The TRAPPC9 mutations were both missense variants; chr8 g.141445217G​>A(ENST00000438773c.853C​>T; p.Arg285Trp) paternally inherited and chr8 g.141321437G​>A (ENST00000438773c.1532C​>T; p.Thr511Met) maternally inherited. Previous reports of TRAPPC9 mutation report mental retardation, microcephaly, corpus callosum hypoplasia, facial asymmetry and overweight habitus(3,4). He does not have most of these features. However, he is more severely affected than his sibling with only one variant, and thus could display a composite phenotype which have been reported in 4.9% of cases of rare diseases investigated with exome sequencing(5).  The NALCN mutations are a missense and a nonsense variant; hg19 chr13 g.101756915G​>A  ENST00000251127c.2723C​>T;p.Pro908Leu) paternally inherited and hg19 chr13 g.102047715C​>T (ENST00000376200c.110G​>A; p.Trp37Ter) maternally inherited. Segregation analysis within the family revealed that the affected sister was also compound heterozygous for the NALCN mutations but not the TRAPPC9 (she carried only the p.The511Met maternally inherited allele). 
Case 3 was found to have compound heterozygous variants in NALCN and another developmental gene ALMS1. Both ALMS1 variants were missense chr2g. 73675690T>C (ENST00000377715 c. 2033A>G; p. Tyr678Cys) paternally inherited and chr2g. 73747141T>G (ENST00000264448 c.9776A>C; p. Asp3259 Ala) maternally inherited. ALMS1 mutations cause Alström syndrome which is characterised by visual impairment, sensorineural hearing loss, insulin insensitivity, cardiomyopathy and multi organ failure.  The patient has been screened and does not match this phenotype, excluding obesity, thus it seems at least one ALMS1 variant is benign. Case 3 has also inherited a missense and a nonsense NALCN variant; hg19 chr13 g. 101742306C>T (ENST00000251127 c. 3281G>A; p. Arg1094Gln) maternally inherited and hg 19 chr13 g. 101759854G>A (ENST00000251127 c. 2563C>T; p. Arg855Ter) paternally inherited. For a schematic view of all the NALCN mutations in relation to their domains please see supplemental figure 2. 
Discussion
There have been 3 published case reports of autosomal recessive, inherited NALCN mutation in humans(6–8). The pervasive traits in each series are hypotonia, developmental delay and constipation but strabismus, poor weight gain and dysmorphic facies are common. Dysrhythmic breathing is previously mentioned in one family(8) and we expand upon this with formal study and detailed description. We add to this, non-consanguineous families and compound heterozygote genotypes. 
Expression of Nalcn is seen in the retrotrapezoid nucleus that regulates breathing in mice(9) and Nalcn knockout mice(10) showed pathological rhythms of breathing characterised by apnoea for 5 seconds then deep breathing for 5 seconds at a rate of 5 apnoeas/min. This respiratory pattern was predictive of death within 24 hours of birth. Reduced expression of the orthologous gene in the snail, Lymnaea Stagnalis(11) was found to reduce breathing time and frequency in comparison to controls. Nerve conduction studies showed this to be caused by abolition of spontaneous firing of the “Right pedal dorsal 1” neuron responsible for respiration. 
Chong et al(12) described de novo mutations in the NALCN region causing an autosomal dominant effect. These individuals were diagnosed with CLIFAHDD syndrome. This appears to be a distinct condition though phenotypic overlap does occur.
Pacemaker neurones are a class of neuron proposed to play a critical role activities such as breathing, sleep-wake cycling, gut motility and cardiac rhythmogenesis(13). Pacemakers require the resting membrane potential (RMP) to be maintained within a tight voltage range(14). Maintenance of RMP is facilitated by NALCN’s passive, intracellular movement of sodium ions. One such collection of pacemaker cells resides in the Pre-Bötzinger Complex (PBC) within the medulla contributing to a complex network influencing our respiratory rhythm (15,16).
Apnoeas only during sleep poses challenges to the narrative of the case but there is precedent with conditions such as CCHS and Brugada syndrome which are also manifest during sleep(17).
The role of oxygen in alleviating this problem requires more study though the sleep study in the figures reveals similarity with periodic breathing of infancy. Premature infants with this conditions show marked improvement of breathing regulation with supplemental oxygen therapy(18).The same effect has also been shown in sleep disordered breathing in Prader-Willi syndrome(19).A knockout animal model in hypoxic and hyperoxic environments may offer insight into the relationship.
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